Abiopharma

Ozaki Yukiko 🟡 adjusted position in 4.4K shares (2 derivative) of NOMURA HOLDINGS INC (NMR) at $8.41 Transaction Date: Apr 24, 2026 | Filing ID: 183654

New Form 3 - Empro Group Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001493152-26-019268 <b>Size:</b> 3 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Ceasing to be a Substantial Shareholder - Fu Tanghai

New Form SCHEDULE 13G - WERNER ENTERPRISES INC <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001214659-26-005145 <b>Size:</b> 6 KB

New Form SCHEDULE 13G - Alkermes plc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0002100119-26-000019 <b>Size:</b> 7 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001918704-26-010923 <b>Size:</b> 875 KB

New Form 3 - Empro Group Inc. <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001493152-26-019267 <b>Size:</b> 3 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001918704-26-010922 <b>Size:</b> 970 KB

(30% Negative) NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXRT) Reports Q2 2026 Financial Results

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-28 <b>AccNo:</b> 0001918704-26-010921 <b>Size:</b> 660 KB